Am Fam Physician. 2003 Sep 1;68(5):923-6. Sierpina VS, Wollschlaeger B, Blumenthal M. Dept. Family Medicine, University of Texas Medical Branch, Galveston, Texas 77555-1123, USA. firstname.lastname@example.org
Ginkgo biloba is commonly used in the treatment of early-stage Alzheimer's disease, vascular dementia, peripheral claudication, and tinnitus of vascular origin. Multiple trials investigating the efficacy of ginkgo for treating cerebrovascular disease and dementia have been performed, and systematic reviews suggest the herb can improve the symptoms of dementia. Ginkgo is generally well tolerated, but it can increase the risk of bleeding if used in combination with warfarin, antiplatelet agents, and certain other herbal medications. Clinical issues of safety, dosing, use in the perioperative period, and pharmacology are addressed in this review.
PMID: 13678141 [PubMed – in process]